Click on image to view larger version.

Figure 3 Fifteen-year survival for patients categorized by ejection fractions (EFs) <30%, 30%–49%, and >50%. Patients with an EF <30% had a dramatic mortality increase during the first year of follow-up, and only 17% were alive at 15 years (p < 0.0001 for differences across the three groups of therapy).